Reddit Posts
Mentions
one company id look at that isnt a ridiculous PE but has had amazing growth recently is MLI. its a copper and aluminum material manufacturer and it seems just a really solid company with really steady growth for a long time then explosive growth recently but still trading at a reasonable PE. its had a bunch of aquisitinons which have fueld both growth and revenue. if you want just a good company, IRMD is a good bet though its had a big rise this year and i woudlnt say its value right now. but its just a good solid company with a long track record of really good growth and earnings. if youre looking for value. Progressive and Charter communications are both much more on the value side. Charter is a 3-5 year buyback play as they will soon free up a ton of cash after completing a cap ex cycle recently Progressive is just a solid company that is better than a lot of its peers but isnt a terrible multiple
It's the #2 longest watched name on my list after IRMD...
Totally. Yeah, might sell some BWAY soon, since it's been on a solid run and it's a cool company, but happy to take profits. I think I might buy some MCK as well, just valuation looks really solid. IRMD was one I never bought as well. Just feels like medical stuff always burns me, so I usually just avoid lol.
Small device makers are so tough. I regret passing on BWAY and IRMD, but so it goes ...
IRMD earnings: Reaffirms Full Year 2025 Revenue and Earnings Guidance Reports record revenue of $19.5 million for the first quarter of 2025, an increase of $1.9 million or 11%, compared to the same period in 2024. Reports GAAP diluted EPS of $0.37 and non-GAAP diluted EPS of $0.42 for the first quarter of 2025, which are increases of 16% and 17%, respectively, compared to the same period in 2024. Declares a regular quarterly cash dividend of $0.17 per common share for the second quarter of 2025, payable on May 30, 2025.
That last part always scares me. IRMD is the same story. On paper, everything looks great. I'm just not medically versed enough to build up strong conviction on a single device. It's why I like UFPT so much, sort of a picks a shovels play on medical devices.
IRMD earnings: Revenue Growth: Q4 revenue increased by 17.4% year-over-year, with full-year revenue up by 23.1%. Net Income: Q4 net income rose to $4.5 million, with a full-year net income of $17.2 million, marking significant increases from the previous year. Earnings Per Share (EPS): GAAP diluted EPS for Q4 was $0.36, and $1.35 for the full year, showing a notable rise from 2022. Non-GAAP Adjustments: Non-GAAP net income for Q4 was $5.0 million, and $18.9 million for the full year, excluding stock-based compensation expense. Cash Flow: Operating cash flow for the year was $13.5 million, with a free cash flow of $5.5 million after significant capital expenditures. Guidance for 2024: iRadimed Corp projects revenue between $72.0 million and $74.0 million and GAAP diluted EPS between $1.37 and $1.47 for the full year.
IRMD calls (except I can't actually afford this)
IRMD reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2023. The fourth-quarter revenue totaled approximately $17.5 million, bringing revenue for 2023 to approximately $65.6 million, up 23% from the prior year.
This is a tough market, there's not a ton of deals out there. I'm looking at IESC or IRMD. I think both are cheap, but not super cheap . I do think the Mexican airports are still cheap (OMAB, PAC), but I also have a big position. NSSC is a decent deal still, IMO. Loaded the boat on that one already though.
Thoughts on IRMD (iradimed) For their third quarter earnings management guided for 2023 EPS to be $1.34-1.37. The stock just dropped below $40. So that's about a 29.2 P/E. In 2018 they made $0.52/share. So in 5 years they've grown at more than a 20% CAGR (it's a little choppy because of covid, so I'm trying to smooth out.). Let's assume 15% CAGR going forward. 2023: $1.35 2024: $1.55 2025: $1.78 2026: $2.05 2027: $2.36 It starts to look cheap if growth continues...In 4 years that's a 16x multiple.
IRMD earnings Reports record revenue of $16.5 million for the third quarter of 2023. GAAP diluted EPS of $0.40 and non-GAAP diluted EPS of $0.43. Third quarter operating income of $5.9 million, an increase of 43% compared to the same period in 2022. Interesting small cap medical device name.
IRMD close to being legit cheap now. Not many 20% growers with no debt out there. BRC possibly breaking down, which would be an interesting pickup. TRNS holding up well. Hammond power... actually up. Again, not many 20% growers with low debt out there. AMR would be nice to add below $200.
Medical devices have been taking it on the chin. This might be an opportunity to find some niche makers going on sale. I've been watching two: STAA, makers of ocular implants. Great growth, low debt. IRMD, makers of MRI compliant devices (it's an interesting niche if you look at the company info). No debt, huge insider ownership. And my bonus, UFPT has pulled back nicely. I own this one, but an absolutely phenomenal company that makes the packaging for medical devices.
IRMD finally breaking lower. Great little small cap medical device name, but it's been very expensive the last few months.
I'm eyeing JBSS and FLT. If they pull back slightly IESC and USLM. IRMD if I'm feeling spicy.
Yeah, physical goods in general seem to be in a downtrend, so it makes sense that the companies that make those goods will be slower too. I do think there will be some great buying opportunities in the next few months though. I am, however, considering USLM, even at its ATH. It's trading at 15x this earnings, possibly less if they put up any growth. Also, IRMD as a medical play.
IRMD earnings Reports record revenue of $16.1 million for the second quarter of 2023 GAAP diluted EPS of $0.33 and non-GAAP diluted EPS of $0.36 Operating income was $5.0 million and increased by 19%. Also raised guidance.
I'm noticing a lot of small caps that have run really hard on the last 6-9 months are starting too roll over a bit. UFPT, JBSS, IRMD, CRVL are a few I've been looking at.
I've been debating selling out of my AMR, leaving just TECK for materials and my energy names. This has been a nice run, but I'm more into potential compounders lately. Also, I'm trying to keep with the theme of undercovered stocks, as they tend to escape the hype. Anyway, since you're always so helpful, I'll throw a few names out there. HWKN (as mentioned below). I'm actively buying at current prices. Growing a water treatment chemicals business through acquisition, and they're seeing a nice flywheel effect. USLM- they own limestone quarries. A bit overbought, but a great compounder. CHE- weirdest company ever. They own a hospice care business (medical exposure) and roto-rooter plumbing. The management is Uber focused on high returns on capital no matter what the opportunity, hence the odd combo. MEDP- also a little overbought, but they do medical testing, so they are agnostic to anything other than a growing medical field. UFPT- also overbought, but another medical supplier that does device packaging. Again, agnostic to anything other than a growing medical field. I own this one. CVCO- modular home builder. Modular homes are much cheaper than site built, so they are well positioned to grow in the current environment. Great balance sheet because they don't require debt to grow like the big homebuilders. This is another I own, and would buy at current prices. I own CP as well. I think their network will really set them apart. Bonus medical name I'm watching.... IRMD- they make advanced cat scan equipment. Very expensive, but an absolutely phenomenal company. Overbought, but interesting to watch.
Yeah, it's been an awesome performer. There's tons of stocks with no or little coverage that perform great though. UFPT CRVL HIFS HWKN IRMD USLM COKE WINA All just great stocks. I'm not sure if you read Crossing Wall Street, but he does a great news letter twice a week. He's big on uncovered names as great performers. You did tell me about WSC. I did a little research, but it didn't really get me that excited. Good company, but it didn't strike me as special enough for more research.
Anyone have insight on IRMD (iradimed)? Seems like a very interesting medical device maker. Huge ROIC, no debt, and a wide moat, combined with high insider ownership.
The problem with that theory is that small caps are not really cheap. There are definitely names out there that have been dropping, but let's say profitable and growing small caps are not cheap. A lot of them have actually run a lot since October. Just going through my watchlist/ownership: UFPT (way up) NSSC (way up) MEDP (way up) CRVL (way up) IRMD (way up) HWKN (actually decent price, but still way up). I could go on. SCCO/FCX are still way up for copper plays. TECK too. Early this year, there was an argument to be made that small caps were cheap, but now....kinda ok. Nothing to really get people excited. Maybe some regional banks. Commodities are ok, but still way up since October (except energy). Basically every small name I start looking into, was a buy 6 months ago, and is kinda....meh now. I guess my point is, there is not a lot to get excited about from a valuation standpoint at least, right now.
I am a bot from /r/wallstreetbets. You submitted one or more banned tickers: SLCA IRMD OIIM ASIX HEXO COWN SIFY DCOM MGI WETF. Message /u/zjz if they're above 1.5 billion-ish market cap and not related to crypto/pennies/OTC.
Alright Apes, check out IRMD (Iradimed). Q2 reports are coming out soon and volume has jumped from an avg of 17k to 300k. Currently up 30% in one week. Keep your eye on this one.
Check out IRMD, it keeps climbing and Q2 reports are in a week. Expect great news from this company
I’m betting on MAXR the most. IRMD & AJRD are a bit more speculative. They all have good fundamentals but thinking MAXR will move based on pure speculation.